Akari Therapeutics Plc (AKTX) News Headlines

▮ More

Date

Headline

10/11/2019 12:26:07 AM 5 Top Losers In Healthcare Sector (AKTX, COCP, AUPH…)

9/13/2019 8:07:31 AM Akari Therapeutics: FDA Grants Orphan Drug Designation For Nomacopan For Bullous Pemphigoid

8/30/2019 7:04:45 AM Akari Therapeutics Says FDA Granted Orphan Drug Designation For Nomacopan

8/29/2019 8:13:49 AM Akari Therapeutics Q2 Net Loss $4.1 Mln Vs Loss Of $8.0 Mln Last Year

8/16/2019 2:09:40 AM 5 Top Losers In Healthcare Sector (JAGX, HROW, IVC…)

4/23/2019 10:21:49 PM 6 Top Gainers In Healthcare Sector (ATOS, AKTX, ATHX...)

4/23/2019 8:35:10 AM Akari Therapeutics Announces Positive Initial Phase II Clinical Data In Orphan Skin Disease Bullous Pemphigoid

4/16/2019 4:20:18 AM AXSM Has Had An Awesome Run. What Awaits These 13 Biotech Stocks In Q2, 2019?

3/13/2019 10:43:58 PM 8 Top Gainers In Healthcare Sector (AKTX, GH, HJLI...)

11/15/2018 6:51:26 AM Akari Therapeutics Q3 Net Loss $3.6 Mln Vs Net Loss $10.4 Mln Last Year

9/27/2018 7:10:02 AM Akari Therapeutics Q2 Net Loss $8.0 Mln Vs Loss Of $0.3 Mln Last Year

9/27/2018 7:07:27 AM Akari Therapeutics Enters Securities Purchase Agreement For Up To $20 Mln With Aspire Capital Fund, LLC

9/12/2018 7:11:43 AM Akari Reports New Preclinical Rheumatoid Arthritis Data And New Clinical Data In Patients With Bullous Pemphigoid

8/17/2018 7:03:49 AM Akari Therapeutics Q1 Net Loss $1.3 Mln Vs Loss Of $12.6 Mln Last Year

6/25/2018 10:10:18 PM XBIO Explodes Over 100%, ZFGN Abuzz, NTRA Grabs Investors' Attention

3/21/2018 7:05:40 AM Akari Therapeutics Q4 Net Loss Widens To $9.3 Mln From $8.3 Mln Last Year

2/6/2018 7:11:02 AM Akari Therapeutics Announces Completion Of Phase II COBALT Trial Of Coversin In Patients With PNH

5/12/2017 6:47:50 AM William Blair Downgrades Akari Therapeutics Plc (AKTX) To Market Perform From Outperform

4/6/2017 7:11:21 AM William Blair Initiates Akari Therapeutics Plc (AKTX) At Outperform

Older Articles